Allogeneic Heart Stem Cells to Achieve Myocardial Regeneration (ALLSTAR)
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT01458405 |
Recruitment Status :
Terminated
(On February 28, 2019, Capricor ceased ongoing follow-up activities and terminated the ALLSTAR trial to focus resourcing on its active CAP-1002 program, HOPE-2.)
First Posted : October 24, 2011
Last Update Posted : April 9, 2019
|
Sponsor:
Capricor Inc.
Collaborators:
National Institutes of Health (NIH)
National Heart, Lung, and Blood Institute (NHLBI)
California Institute for Regenerative Medicine (CIRM)
Information provided by (Responsible Party):
Capricor Inc.
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : | Terminated |
---|---|
Actual Primary Completion Date : | July 3, 2017 |
Actual Study Completion Date : | February 28, 2019 |
Certification/Extension First Submitted : | October 5, 2018 |
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):